Osteopontin mediates Citrobacter rodentium-induced colonic epithelial cell hyperplasia and attaching-effacing lesions

American Journal of Pathology

Volumn 177, Issue 3, 2010, Pages 1320-1332

  Wine, Eytan ^a   Shen Tu, Grace ^b,c   Gareau, Mélanie G ^b,c   Goldberg, Harvey A ^d   Licht, Christoph ^b,c   Ngan, Bo Yee ^b,c   Sorensen, Esben S ^e   Greenaway, James ^c   Sodek, Jaro ^c   Zohar, Ron ^c   Sherman, Philip M ^b,c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; CELL HYPERPLASIA; CITROBACTER RODENTIUM; COLITIS; COLON MUCOSA; CONTROLLED STUDY; FIBROBLAST; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLENOMEGALY; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; WILD TYPE;

EID: 77956505984     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.091068     Document Type: Article

References (49)

1. Hashimoto M, Sun D, Rittling SR, Denhardt DT, Young W: Osteopontin- deficient mice exhibit less inflammation, greater tissue damage, and impaired locomotor recovery from spinal cord injury compared with wild-type controls. J Neurosci 2007, 27:3603-3611
2. Scatena M, Liaw L, Giachelli CM: Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007, 27:2302-2309
3. Morimoto J, Inobe M, Kimura C, Kon S, Diao H, Aoki M, Miyazaki T, Denhardt DT, Rittling S, Uede T: Osteopontin affects the persistence of beta-glucan-induced hepatic granuloma formation and tissue injury through two distinct mechanisms. Int Immunol 2004, 16:477-488
4. Neish AS: Microbes in gastrointestinal health and disease. Gastroenterology 2009, 136:65-80
5. Xavier RJ, Podolsky DK: Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434
6. Deng W, Vallance BA, Li Y, Puente JL, Finlay BB: Citrobacter rodentium translocated intimin receptor (Tir) is an essential virulence factor needed for actin condensation, intestinal colonization and colonic hyperplasia in mice. Mol Microbiol 2003, 48:95-115
7. Eckmann L: Animal models of inflammatory bowel disease: lessons from enteric infections. Ann NY Acad Sci 2006, 1072:28-38
8. Borenshtein D, McBee ME, Schauer DB: Utility of the Citrobacter rodentium infection model in laboratory mice. Curr Opin Gastroenterol 2008, 24:32-37
9. Zhong J, Eckhardt ER, Oz HS, Bruemmer D, de Villiers WJ: Osteopontin deficiency protects mice from Dextran sodium sulfate-induced colitis. Inflamm Bowel Dis 2006, 12:790-796
10. da Silva AP, Pollett A, Rittling SR, Denhardt DT, Sodek J, Zohar R: Exacerbated tissue destruction in DSS-induced acute colitis of OPN-null mice is associated with downregulation of TNF-alpha expression and non-programmed cell death. J Cell Physiol 2006, 208:629-639
11. Heilmann K, Hoffmann U, Witte E, Loddenkemper C, Sina C, Schreiber S, Hayford C, Holzlohner P, Wolk K, Tchatchou E, Moos V, Zeitz M, Sabat R, Gunthert U, Wittig BM: Osteopontin as two-sided mediator of intestinal inflammation. J Cell Mol Med 2008, 13:1162-1174
12. da Silva AP, Ellen RP, Sorensen ES, Goldberg HA, Zohar R, Sodek J: Osteopontin attenuation of dextran sulfate sodium-induced colitis in mice. Lab Invest 2009, 89:1169-1181
13. Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE, Kowalski AJ, Noda M, Denhardt DT: Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 1998, 13:1101-1111
14. Schack L, Lange A, Kelsen J, Agnholt J, Christensen B, Petersen TE, Sorensen ES: Considerable variation in the concentration of osteopontin in human milk, bovine milk, and infant formulas. J Dairy Sci 2009, 92:5378-5385
15. Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, Buller HA, Dekker J, Van Seuningen I, Renes IB, Einerhand AW: Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 2006, 131:117-129
16. LeBlanc PM, Yeretssian G, Rutherford N, Doiron K, Nadiri A, Zhu L, Green DR, Gruenheid S, Saleh M: Caspase-12 modulates NOD signaling and regulates antimicrobial peptide production and mucosal immunity. Cell Host Microbe 2008, 3:146-157
17. Zohar R, Zhu B, Liu P, Sodek J, McCulloch CA: Increased cell death in osteopontin-deficient cardiac fibroblasts occurs by a caspase-3- independent pathway. Am J Physiol Heart Circ Physiol 2004, 287:H1730-H1739
18. Sorensen ES, Petersen TE: Purification and characterization of three proteins isolated from the proteose peptone fraction of bovine milk. J Dairy Res 1993, 60:189-197
19. Hunter GK, Grohe B, Jeffrey S, O'Young J, Sorensen ES, Goldberg HA: Role of phosphate groups in inhibition of calcium oxalate crystal growth by osteopontin. Cells Tissues Organs 2009, 189:44-50
20. Qu-Hong, Dvorak AM: Ultrastructural localization of osteopontin immunoreactivity in phagolysosomes and secretory granules of cells in human intestine. Histochem J 1997, 29:801-812
21. Sato T, Nakai T, Tamura N, Okamoto S, Matsuoka K, Sakuraba A, Fukushima T, Uede T, Hibi T: Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut 2005, 54:1254-1262
22. Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S: Citrobacter rodentium of mice and man. Cell Microbiol 2005, 7:1697-1706
23. Vallance BA, Deng W, Jacobson K, Finlay BB: Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium. Infect Immun 2003, 71:3443-3453 (Pubitemid 36637573)
24. Borenshtein D, Nambiar PR, Groff EB, Fox JG, Schauer DB: Development of fatal colitis in FVB mice infected with Citrobacter rodentium. Infect Immun 2007, 75:3271-3281 (Pubitemid 47040928)
25. Berntman E, Rolf J, Johansson C, Anderson P, Cardell SL: The role of CD1d-restricted NK T lymphocytes in the immune response to oral infection with Salmonella typhimurium. Eur J Immunol 2005, 35:2100-2109 (Pubitemid 41015049)
26. Tobe T, Sasakawa C: Species-specific cell adhesion of enteropathogenic Escherichia coli is mediated by type IV bundle-forming pili. Cell Microbiol 2002, 4:29-42 (Pubitemid 34121276)
27. Masuda H, Takahashi Y, Asai S, Takayama T: Distinct gene expression of osteopontin in patients with ulcerative colitis. J Surg Res 2003, 111:85-90 (Pubitemid 36808703)
28. Agnholt J, Kelsen J, Schack L, Hvas CL, Dahlerup JF, Sorensen ES: Osteopontin, a protein with cytokine-like properties, is associated with inflammation in Crohn's disease. Scand J Immunol 2007, 65:453-460 (Pubitemid 46632541)
29. Gordon JN, MacDonald TT: Osteopontin: a new addition to the constellation of cytokines which drive T helper cell type 1 responses in Crohn's disease. Gut 2005, 54:1213-1215
30. Xu G, Nie H, Li N, Zheng W, Zhang D, Feng G, Ni L, Xu R, Hong J, Zhang JZ: Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 2005, 115:1060-1067 (Pubitemid 40489411)
31. Chabas D, Baranzini SE, Mitchell D, Bernard CC, Rittling SR, Denhardt DT, Sobel RA, Lock C, Karpuj M, Pedotti R, Heller R, Oksenberg JR, Steinman L: The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001, 294:1731-1735
32. Hur EM, Youssef S, Haws ME, Zhang SY, Sobel RA, Steinman L: Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat Immunol 2007, 8:74-83 (Pubitemid 46242361)
33. Kon S, Ikesue M, Kimura C, Aoki M, Nakayama Y, Saito Y, Kurotaki D, Diao H, Matsui Y, Segawa T, Maeda M, Kojima T, Uede T: Syndecan- 4 protects against osteopontin-mediated acute hepatic injury by masking functional domains of osteopontin. J Exp Med 2008, 205:25-33 (Pubitemid 351185712)
34. Zhu B, Suzuki K, Goldberg HA, Rittling SR, Denhardt DT, McCulloch CA, Sodek J: Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. J Cell Physiol 2004, 198:155-167 (Pubitemid 38120976)
35. Koh A, da Silva AP, Bansal AK, Bansal M, Sun C, Lee H, Glogauer M, Sodek J, Zohar R: Role of osteopontin in neutrophil function. Immunology 2007, 122:466-475
36. Kawada M, Arihiro A, Mizoguchi E: Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease. World J Gastroenterol 2007, 13:5581-5593 (Pubitemid 350031478)
37. Wirtz S, Neufert C, Weigmann B, Neurath MF: Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007, 2:541-546 (Pubitemid 47040018)
38. Khalil PN, Weiler V, Nelson PJ, Khalil MN, Moosmann S, Mutschler WE, Siebeck M, Huss R: Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology 2007, 132:944-954 (Pubitemid 46440862)
39. Sodek J, Batista Da Silva AP, Zohar R: Osteopontin and mucosal protection. J Dent Res 2006, 85:404-415
40. Kuhl AA, Kakirman H, Janotta M, Dreher S, Cremer P, Pawlowski NN, Loddenkemper C, Heimesaat MM, Grollich K, Zeitz M, Farkas S, Hoffmann JC: Aggravation of different types of experimental colitis by depletion or adhesion blockade of neutrophils. Gastroenterology 2007, 133:1882-1892 (Pubitemid 350180801)
41. Wang KX, Shi Y, Denhardt DT: Osteopontin regulates hindlimb-unloading- induced lymphoid organ atrophy and weight loss by modulating corticosteroid production. Proc Natl Acad Sci 2007, 104: 14777-14782 (Pubitemid 350003219)
42. Schack L, Stapulionis R, Christensen B, Kofod-Olsen E, Skov Sorensen UB, Vorup-Jensen T, Sorensen ES, Hollsberg P: Osteopontin enhances phagocytosis through a novel osteopontin receptor, the alphaXbeta2 integrin. J Immunol 2009, 182:6943-6950
43. Higgins LM, Frankel G, Connerton I, Goncalves NS, Dougan G, MacDonald TT: Role of bacterial intimin in colonic hyperplasia and inflammation. Science 1999, 285:588-591 (Pubitemid 129515297)
44. Frankel G, Phillips AD: Attaching effacing Escherichia coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal. Cell Microbiol 2008, 10:549-556 (Pubitemid 351194084)
45. Ritchie JM, Brady MJ, Riley KN, Ho TD, Campellone KG, Herman IM, Donohue-Rolfe A, Tzipori S, Waldor MK, Leong JM: EspFU, a type III-translocated effector of actin assembly, fosters epithelial association and late-stage intestinal colonization by E. coli O157:H7. Cell Microbiol 2008, 10:836-847
46. Goosney DL, DeVinney R, Finlay BB: Recruitment of cytoskeletal and signaling proteins to enteropathogenic and enterohemorrhagic Escherichia coli pedestals. Infect Immun 2001, 69:3315-3322 (Pubitemid 32332230)
47. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR: Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 2009, 139: 485-498
48. Collins CB, Ho J, Wilson TE, Wermers JD, Tlaxca JL, Lawrence MB, Solga M, Lannigan J, Rivera-Nieves J: CD44 deficiency attenuates chronic murine ileitis. Gastroenterology 2008, 135:1993-2002
49. Lenga Y, Koh A, Perera AS, McCulloch CA, Sodek J, Zohar R: Osteopontin expression is required for myofibroblast differentiation. Circ Res 2008, 102:319-327